Compare Stocks

→ World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MAYNF Mayne Pharma Group	$4.54	$4.31	$1.90 ▼ $4.59	N/A	N/A	1,272 shs	50 shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MAYNF Mayne Pharma Group	0.00%	+1.57%	+1.11%	+32.55%	+72.62%

World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MAYNF Mayne Pharma Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MAYNF Mayne Pharma Group	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MAYNF Mayne Pharma Group	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MAYNF Mayne Pharma Group	N/A	$0.04	123.89	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MAYNF Mayne Pharma Group	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
MAYNF Mayne Pharma Group	15.80%

Insider Ownership

Company	Insider Ownership
MAYNF Mayne Pharma Group	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MAYNF Mayne Pharma Group	780	N/A	N/A	Not Optionable

RCE, ANP, MAYNF, and MYX Headlines

Source	Headline
	Mayne Pharma Group Limited afr.com - April 23 at 8:32 AM
	Mayne Pharma Group (OTCMKTS:MAYNF) Trading Up 1.6% americanbankingnews.com - April 23 at 1:48 AM
	Mayne Pharma Group Limited (ASX: MYX) - Share Price and Research intelligentinvestor.com.au - March 15 at 9:37 PM
	Winners and Losers: Mayne Pharma rises during busy earnings season indaily.com.au - March 3 at 10:48 PM
	Mayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call Transcript seekingalpha.com - February 28 at 8:27 PM
	Mayne Pharma Group Limited (MAYNF) finance.yahoo.com - February 28 at 8:27 PM
	Mayne Pharma Group reports 1H results msn.com - February 27 at 12:49 PM
	Mithra sells position in Mayne Pharma to free up cash pharmaceutical-technology.com - February 15 at 3:34 PM
	Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference finance.yahoo.com - December 29 at 7:23 PM
	Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Mayne Pharma Group (OtherMAYNF) and Biogen (BIIB) markets.businessinsider.com - December 6 at 10:33 PM
	While institutions invested in Mayne Pharma Group Limited (ASX:MYX) benefited from last week's 12% gain, retail investors stood to gain the most finance.yahoo.com - November 18 at 8:12 PM
	Shawn O’Brien Buys Handful Of Shares In Mayne Pharma Group finance.yahoo.com - October 28 at 8:40 PM
	Strong week for Mayne Pharma Group (ASX:MYX) shareholders doesn't alleviate pain of five-year loss finance.yahoo.com - October 23 at 12:19 AM
	News - Mayne Pharma thepharmaletter.com - September 4 at 6:20 PM
	Mayne Pharma Group Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag finance.yahoo.com - September 1 at 4:52 PM
	Wilsons Sticks to Its Buy Rating for Mayne Pharma Group (MAYNF) markets.businessinsider.com - June 13 at 10:00 PM
	Infomedia wrangler Viburnum butts heads with Mayne Pharma’s board afr.com - May 16 at 7:34 AM
	There's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted Revenues finance.yahoo.com - April 18 at 3:07 AM
	Dr. Reddy’s acquiring Mayne Pharma’s U.S. generic portfolio for $105 million thehindu.com - March 24 at 4:08 PM
	Dr. Reddy’s Acquires Mayne Pharma Portfolio pharmaceuticalcommerce.com - March 8 at 12:27 AM
	Dr. Reddy’s Expands in Women’s Health With $90M Deal for Mayne’s U.S. Meds medcitynews.com - March 2 at 4:44 AM
	Mayne Pharma Group Limited (ASX:MYX) Shares Could Be 49% Below Their Intrinsic Value Estimate finance.yahoo.com - March 1 at 6:44 PM
	Dr Reddy’s to buy Mayne Pharma's US generic portfolio for $105 million livemint.com - February 28 at 9:36 PM
	Dr. Reddy's Acquires Mayne Pharma’s U.S. Generic Product Portfolio contractpharma.com - February 28 at 9:36 PM

Media Sentiment Over Time

Top Headlines

3 Companies Buying Back Stock Before New Highs
April 1, 2024 6:05 AM
View 3 Companies Buying Back Stock Before New Highs
Banks Think Small Cap Stocks Need to Catch Up: 3 Winners
April 3, 2024 8:54 AM
View Banks Think Small Cap Stocks Need to Catch Up: 3 Winners
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
April 19, 2024 8:59 AM
View Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
April 15, 2024 7:40 AM
View Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
These are the Top 4 Stocks for Buybacks in 2024
April 18, 2024 7:00 AM
View These are the Top 4 Stocks for Buybacks in 2024

All Headlines

Company Descriptions

Mayne Pharma Group

OTCMKTS:MAYNF

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial